Tuesday, April 09, 2024 8:27:02 AM
So it's not going to Expert Market this month.
I didn't see this rule change (effective 12/31/2023) and neither did Whelan. If she had known, she wouldn't have filed that "Notification of Late Filing" so early.
I don't know when the Attorney Letter is due -- probably also extended 30 days. Not going to bother looking it up.
Meanwhile, Ilfeld's opioid study was supposed to finish last week:
https://clinicaltrials.gov/study/NCT05399355
Took him about six months to publish the results of the phantom pain pilot study, which is quite fast. Maybe he can get the opioid study published by EOY and BIEL can use it to convince the CMS to accept it as proof for NOPAIN reimbursement. NOPAIN is pretty much the only pump going here. Hope he doesn't wait for the SofPulse trial to finish and publish them together.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM